The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments. This has led to development of this protocol in order to make available tranexamic acid as a potentially effective menorrhagia therapy option in women with an underlying bleeding disorder. We anticipate that Tranexamic Acid may be a beneficial choice for controlling menorrhagia in bleeding disorder patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mary M. Gooley Hemophilia Center
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• all menstruating women regardless of age

• Women with heavy periods as measured by pictorial blood assessment chart

• Women diagnosed with a bleeding disorder

Exclusion Criteria:

• Acquired defective color vision

• Factor VIII, Factor IX, FactorXI levels >250%

• An inherited thrombophilic defect detected because of a positive family or personal history of thrombosis

• Current use of oral contraceptives